Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Precision Health Database|Search|PHGKB

Heart, Lung, Blood and Sleep Disorders

Last data update: Sep 29, 2023. (Total: 61661 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 24 (of 24 Records)

Query Trace:
Thromboembolic Disease in Haemophilic Patients Undergoing Major Orthopaedic Surgery: Is Thromboprophylaxis Mandatory?
Badulescu Oana Viola et al. Diagnostics (Basel, Switzerland) 2023 13(1)
Epidemiology and prevention of venous thromboembolism.
Lutsey Pamela L et al. Nature reviews. Cardiology 2022
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
Barda Noam et al. The New England journal of medicine 2021
Short- and long-term outcomes for single-port risk-reducing salpingo-oophorectomy with and without hysterectomy for women at risk for gynecologic cancer.
Carr Caitlin E et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020 Sep
Venous Thromboembolism (Blood Clots) and Cancer
CDC, October 2019
Thrombin generation profile in non-thrombotic factor V Leiden carriers.
Billoir Paul et al. Journal of thrombosis and thrombolysis 2019 Apr 47(3) 473-477
CLINGEN Actionability Report for Factor V Leiden, Homozygous (also includes compound heterozygous FVL + prothrombin G20210A) - F5
ClinGen Actionability Working Group
CLINGEN Actionability Report for von Willebrand Disease - VWF
ClinGen Actionability Working Group
CLINGEN Actionability Report for Thrombophilia due to protein S deficiency - PROS1
ClinGen Actionability Working Group
CLINGEN Actionability Report for Factor V Leiden, Heterozygous - F5
ClinGen Actionability Working Group
CLINGEN Actionability Report for Thrombophilia due to protein C deficiency - PROC
ClinGen Actionability Working Group
Deep vein thrombosis during long-term surveillance of patients with liver transplantation.
Balaceanu Alice et al. Irish journal of medical science 2019 Mar
Pharmacogenetics of Warfarin in a Diverse Patient Population.
Mak May et al. Journal of cardiovascular pharmacology and therapeutics 2019 May 1074248419843530
Cost Effectiveness of Genotype-Guided Warfarin Dosing in Patients with Mechanical Heart Valve Replacement Under the Fee-for-Service System.
Kim Dong-Jin et al. Applied health economics and health policy 2017 Oct 15(5) 657-667
Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Viswanathan Meera et al. JAMA 2018 Jun 319(24) 2532-2551
The impact of real-world cardiovascular-related pharmacogenetic testing in an insured population.
Billings Jennifer et al. International journal of clinical practice 2018 May e13088
Laboratory Testing for Activated Protein C Resistance (APCR).
Mohammed Soma et al. Methods in molecular biology (Clifton, N.J.) 2017 1646137-143
Personal Stories of Deep Vein Thrombosis
Personal Stories of People Living with Deep Vein Thrombosis and Pulmonary Embolism
Are you at risk for clots?
A family history of blood clots can increase a person?s risk.
Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
Gage Brian F, et al. JAMA 2017 0 0. (12) 1115-1124
Thrombophilia testing results in patients with a first venous thromboembolic event: should the selection criteria for testing be revisited?
Hirmerova Jana et al. International angiology : a journal of the International Union of Angiology 2017 Apr 36(2) 167-173
Genetics of Venous Thrombosis: update in 2015.
Morange Pierre-Emmanuel et al. Thrombosis and haemostasis 2015 Nov (5) 910-9
Family history of venous thromboembolism (VTE) and risk of recurrent hospitalization for VTE: a nationwide family study in Sweden.
TOP